Skip to content
lifestyle.pspl.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer’s Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
April 30, 2026
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
April 30, 2026
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
April 29, 2026
Acumen Pharmaceuticals to Showcase Advances in Alzheimer’s Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
March 3, 2026
←
Previous Page
1
2